ANI Pharmaceuticals, Inc. (ANIP) on Decifer

Decifer ranks ANIP number 91 of 269 tracked names on durable business quality.

Why it ranks here

• Sales are growing about 44% a year, faster than 87 in 100 companies we measure.
• It keeps about 17 cents of every sales dollar as cash, safer than 78 in 100 companies we measure.
• It earns about 8% a year on the money put into the business, better than 47 in 100 companies we measure.
• It costs about 15 times its yearly profit; the middle of its industry is 32. Cheaper than 89 in 100 companies we measure, against their own industries.

The current read

The evidence on ANIP lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Read the full ANIP research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.